Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.190NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.11.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDLNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.29.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.29.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.299NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.149NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.300NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.179NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.125NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
G.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.438NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.497NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.30 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.85 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.11.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.367NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.385NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.244NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.17.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.493NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.351.2 (Beta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.640.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.352NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.251NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used